I'm not sure if the scientific results could be better:1. Independant study saying interim results say DRUG IS SAFE, recommending completion of trail with NO CHANGES TO PROTOCOL NECESSARY2. Preliminary findings SHOW the overall (FDA approved) efficacy target for trail EXCEEDS EXPECTATIONS (30% vs. 19%) and the trail isn't even completeAt this point the company needs to come out and say they have the CASH to survive!!! They do this... the SP could be north of $2/share.My guess is they have filed these NRs with NASDAQ and are asking for relief against listing qualifications. They will get it.How is that for optimistic.celtic
What listing requirement - the NASDAQ supsended the minimum price requirement.
Market cap requirement. HNAB could receive notification of delisting on Mar 4.I received email from CFO last week... say's, if notification is received, HNAB will appeal the decs